A bit more info about takeover timing towards the end of the interview (source: Eureka Report)
Alan asked about transitional arrangement or transitional funding method using the ASX to fund some trials as a transition to big pharma.
LC: "Perhaps. I’ll always develop my molecules and technology like I’m going to take it all the way to marketing, only because if big pharma comes to look at it, they know exactly what our plans are and we know our molecule more than they would. So I always plan on successes across all our program but likely what’s going to be taken up is that big pharma will notice us even before we have a chance to get it into a registrational or a phase 3 study."
Ann: Letter to IMUOA & IMUOB Option Share Holders, page-24
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |